Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 0.7× sales vs its 2.7× historical median P/S.
Fair value ≈ $16.43 · price $4.58 today
Undervalued · 72% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$NURO expanding into Germany (Munich) is a real stress test for autonomy, not just a PR milestone.
Germany is one of the toughest regulatory environments in the world — if their stack works there, the portability thesis gets real credibility.
The interesting part is the link to Uber. A universal Level 4 driver plugging into an existing global ride network changes the scaling equation — distribution starts to matter more than hardware.
We’re moving toward a world where the autonomy stack is the product, and vehicles become interchangeable hardware.
Even if Nuro succeeds in Germany, the “Android for autonomy” race is still wide open.
Big question: who scales reliable autonomy across borders first?
Follow me 👉@ChipDistribution7 for real-time updates and everything. Let’s make moves!
$BB + $LCID + $UBER + $NURO + $NVDA
Gemini3Pro= "The announcement of the Lucid-Nuro-Uber robotaxi alliance at CES 2026 is effectively a "paid advertisement" for the QNX ecosystem.
Here is the breakdown of why this specific partnership drives revenue and validation for BlackBerry:
1. The "Hidden" Tech Stack
While the press release highlights Lucid (Car), Nuro (AI), and Uber (Network), the technical reality relies on the "NVIDIA + QNX" standard.
The Hardware: Reports from CES confirm the Nuro software runs on the NVIDIA DRIVE AGX platform (likely the Hyperion architecture).
The OS: Nuro has historically built its autonomous safety stack on QNX. You cannot run a Level 4 autonomous car on public roads without a safety-certified operating system (ISO 26262), and QNX is the industry standard for that layer.
The Connection: Since NVIDIA DRIVE platforms use QNX as the foundational safety OS, this fleet deployment effectively guarantees QNX royalties for every vehicle."
https://media.lucidmotors.com/en/newsitem/1061-lucid-nuro-and-uber-unveil-global-robotaxi-at-ces-announce-autonomous-on-road-testing
$NURO got payment for CVR , a huge 0,0907 € /cvr , my broker has delisted the CVR , disapointed , i thought i could receive the proceeds from sale of DPN Check to Fukuda , and thought the CVR would last until 2030 .
$NURO I’m going to be streaming FOMC all day tomorrow. Chuck4options on you tube! It’s going to be all money talk. Calling strikes and making plays. Play it if you want, or wait till you hear something good. I’m making it a daily thing but today is FOMC day. If who your watching isn’t activity and freely holding your hand to make sure you make money. Then join me on my daily stream! You don’t have to join discord or sign up. Just join the stream and get ready to make tons of cash. Chuck4options
electroCore announced it has completed the merger with NeuroMetrix, expanding its portfolio to include Quell Fibromyalgia Solution, strengthening its commercial reach, and positioning the company as a diversified leader in non-invasive health and wellness solutions $ECOR $NURO
https://biotuesdays.com/2025/05/02/electrocore-acquires-neurometrix-gaining-access-to-quell-platform/
$NURO merger officially closed - shares converted to $4.49 cash + contingent value rights. Trading halted as stock delists. Final chapter for the once-promising neurotech play. Now it's all about execution on those Quell sales milestones through 2030. CVRs = lottery tickets with better odds than most biotechs.
https://www.sec.gov/Archives/edgar/data/1289850/000164117225008179/form8-k.htm
$NURO Quell tech looks promising. Digging into their fibromyalgia and CIPN potential. Might be an undervalued play in chronic pain management. FDA breakthrough designation gives some credibility. Watching closely for next moves in strategic review. great article: https://beyondspx.com/article/neurometrix-nuro-a-pioneering-medtech-navigating-challenges-in-chronic-pain-and-neuropathy-diagnostics
I found you an Overbought RSI (Relative Strength Index) on the daily chart of NeuroMetrix Inc. Is that bullish or bearish? $NURO #NeuroMetrix #RsiOverbought #NASDAQ
